Literature DB >> 15244390

An algorithm for the management of restless legs syndrome.

Michael H Silber1, Bruce L Ehrenberg, Richard P Allen, Mark J Buchfuhrer, Christopher J Earley, Wayne A Hening, David B Rye.   

Abstract

Restless legs syndrome (RLS) is a common disorder with a prevalence of 5% to 15%. Primary care physicians must become familiar with management of this disorder. This algorithm for the management of RLS was written by members of the Medical Advisory Board of the Restless Legs Syndrome Foundation and is based on scientific evidence and expert opinion. Restless legs syndrome is divided into intermittent, daily, and refractory types. Nonpharmacological approaches, including mental alerting activities, avoiding substances or medications that may exacerbate RLS, and addressing the possibility of iron deficiency, are discussed. The role of carbidopa/levodopa, dopamine agonists, opioids, benzodiazepines, and anticonvulsants for the different types of the disorder is delineated.

Entities:  

Mesh:

Year:  2004        PMID: 15244390     DOI: 10.4065/79.7.916

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  37 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Assessment and treatment of common pediatric sleep disorders.

Authors:  Sricharan Moturi; Kristin Avis
Journal:  Psychiatry (Edgmont)       Date:  2010-06

Review 3.  Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mechanisms and treatment.

Authors:  R Gupta; M Dhyani; T Kendzerska; S R Pandi-Perumal; A S BaHammam; P Srivanitchapoom; S Pandey; M Hallett
Journal:  Acta Neurol Scand       Date:  2015-10-19       Impact factor: 3.209

4.  The burden of restless legs syndrome: an assessment of work productivity, sleep, psychological distress, and health status among diagnosed and undiagnosed individuals in an internet-based panel.

Authors:  Sheri Fehnel; Laurie Zografos; Tammy Curtice; Hemal Shah; Lori McLeod
Journal:  Patient       Date:  2008-07-01       Impact factor: 3.883

Review 5.  Iron for restless legs syndrome.

Authors:  Lynn M Trotti; Srinivas Bhadriraju; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 6.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Efficacy and safety of pramipexole in restless legs syndrome.

Authors:  John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

Review 8.  Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.

Authors:  Susan Mackie; John W Winkelman
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

9.  Treatment of sleep disorders in elderly patients.

Authors:  John J Harrington; Alon Y Avidan
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.598

Review 10.  Diagnosis and management of restless legs syndrome in children.

Authors:  Narong Simakajornboon; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep Med Rev       Date:  2009-01-31       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.